Current Value
$68.881 Year Return
Current Value
$68.881 Year Return
PBE - Invesco Biotechnology & Genome ETF contains 32 holdings. The top holdings include GILD, NTRA, AMGN, INCY, UTHR
Name | Weight |
---|---|
5.42% | |
![]() | 5.3% |
![]() | 5.16% |
![]() | 5.04% |
4.73% | |
4.71% | |
![]() | 4.51% |
![]() | 4.27% |
3.24% | |
3.19% | |
3.19% | |
3.18% | |
3.18% | |
3.16% | |
3.14% | |
2.97% | |
![]() | 2.95% |
2.79% | |
![]() | 2.72% |
2.72% | |
![]() | 2.72% |
2.68% | |
2.65% | |
![]() | 2.63% |
2.57% | |
![]() | 2.48% |
2.27% | |
![]() | 2.25% |
2.21% | |
![]() | 1.81% |
Sector | Weight |
---|---|
Health Care | 99.84% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BNED | 0.20% | $334.17M | -85.82% | 0.00% |
OXBR | -0.27% | $28.73M | +367.44% | 0.00% |
LPTH | -0.28% | $129.31M | +107.64% | 0.00% |
NEUE | -0.35% | $60.59M | +0.41% | 0.00% |
SRRK | -0.73% | $3.92B | +161.49% | 0.00% |
HEES | 0.79% | $3.21B | +62.34% | 1.25% |
TRVG | 0.86% | $67.55M | +22.86% | 0.00% |
UUU | 0.87% | $5.00M | +56.52% | 0.00% |
VHC | 1.56% | $33.15M | +22.79% | 0.00% |
NNVC | 1.63% | $18.65M | +12.07% | 0.00% |
HIHO | 1.76% | $8.23M | -7.46% | 6.42% |
CCEC | -1.88% | $1.12B | +6.93% | 3.14% |
QXO | 2.48% | $5.90B | -83.48% | 0.00% |
FATBB | 2.50% | $77.16M | -6.90% | 13.30% |
CHD | 2.86% | $26.26B | +6.39% | 1.05% |
LITB | 3.09% | $18.38M | -83.50% | 0.00% |
XGN | 3.36% | $94.01M | +171.94% | 0.00% |
CATO | 3.69% | $69.42M | -50.44% | 14.96% |
BACK | 3.95% | $1.27M | -69.51% | 0.00% |
PSQH | -3.98% | $161.03M | -17.51% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TECH | 64.58% | $11.96B | +13.40% | 0.42% |
BEAM | 60.40% | $2.30B | +0.91% | 0.00% |
ILMN | 59.60% | $19.77B | -10.47% | 0.00% |
BN | 59.32% | $89.92B | +49.96% | 0.53% |
NTLA | 58.52% | $1.07B | -59.69% | 0.00% |
VCYT | 57.40% | $3.50B | +85.55% | 0.00% |
BPMC | 57.34% | $7.01B | +48.75% | 0.00% |
REGN | 56.96% | $78.76B | -23.63% | 0.00% |
AVNT | 56.76% | $3.90B | +17.73% | 2.43% |
IDYA | 56.68% | $2.17B | -42.31% | 0.00% |
CRL | 56.62% | $8.48B | -24.11% | 0.00% |
SCL | 56.23% | $1.40B | -30.51% | 2.41% |
CRSP | 56.09% | $3.60B | -35.76% | 0.00% |
AIN | 56.03% | $2.60B | -5.82% | 1.26% |
CTS | 55.87% | $1.44B | +12.29% | 0.33% |
PLRX | 55.69% | $763.71M | -21.42% | 0.00% |
BNT | 55.45% | $7.62B | +49.24% | 0.00% |
HHH | 55.43% | $3.81B | +2.88% | 0.00% |
HLMN | 55.36% | $1.97B | +14.81% | 0.00% |
DNLI | 55.19% | $3.40B | +39.17% | 0.00% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
IBB | 90.99% | $6.48B | 0.45% | |
FBT | 88.43% | $1.20B | 0.56% | |
XBI | 86.39% | $6.03B | 0.35% | |
BBH | 84.73% | $397.92M | 0.35% | |
GNOM | 83.61% | $69.52M | 0.5% | |
XPH | 78.19% | $163.26M | 0.35% | |
ARKG | 77.99% | $1.17B | 0.75% | |
FXH | 77.95% | $1.07B | 0.62% | |
PTH | 75.14% | $126.81M | 0.6% | |
SCHA | 73.27% | $18.77B | 0.04% | |
IWO | 73.15% | $12.71B | 0.24% | |
VTWO | 72.94% | $11.77B | 0.1% | |
IWM | 72.85% | $73.84B | 0.19% | |
IWC | 72.81% | $970.42M | 0.6% | |
NUSC | 72.80% | $1.26B | 0.31% | |
ESML | 72.67% | $1.93B | 0.17% | |
CPRJ | 72.46% | $51.01M | 0.69% | |
KJAN | 72.16% | $353.52M | 0.79% | |
VHT | 72.15% | $17.09B | 0.1% | |
MOAT | 72.08% | $15.12B | 0.46% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -15.94% | $21.80B | +12.91% | 1.13% |
HUSA | -11.95% | $21.33M | -4.90% | 0.00% |
PULM | -8.81% | $26.99M | +325.94% | 0.00% |
STG | -8.78% | $35.15M | -22.06% | 0.00% |
TCTM | -6.49% | $4.26M | -47.98% | 0.00% |
SYPR | -6.44% | $53.87M | +21.24% | 0.00% |
CME | -6.18% | $87.08B | +17.61% | 4.29% |
K | -5.42% | $28.22B | +52.47% | 2.76% |
PRPO | -4.83% | $10.21M | -0.26% | 0.00% |
BTCT | -4.58% | $28.90M | +54.31% | 0.00% |
MNOV | -4.33% | $93.68M | +36.43% | 0.00% |
PSQH | -3.98% | $161.03M | -17.51% | 0.00% |
CCEC | -1.88% | $1.12B | +6.93% | 3.14% |
SRRK | -0.73% | $3.92B | +161.49% | 0.00% |
NEUE | -0.35% | $60.59M | +0.41% | 0.00% |
LPTH | -0.28% | $129.31M | +107.64% | 0.00% |
OXBR | -0.27% | $28.73M | +367.44% | 0.00% |
BNED | 0.20% | $334.17M | -85.82% | 0.00% |
HEES | 0.79% | $3.21B | +62.34% | 1.25% |
TRVG | 0.86% | $67.55M | +22.86% | 0.00% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
VIXY | -49.45% | $195.31M | 0.85% | |
BTAL | -48.96% | $270.93M | 1.43% | |
TAIL | -30.54% | $65.40M | 0.59% | |
USDU | -24.85% | $295.27M | 0.5% | |
UUP | -23.25% | $408.05M | 0.77% | |
CTA | -13.93% | $624.20M | 0.76% | |
TPMN | -12.25% | $33.91M | 0.65% | |
UGA | -9.55% | $103.96M | 0.97% | |
DBE | -9.41% | $54.84M | 0.77% | |
USL | -9.09% | $48.19M | 0.85% | |
BNO | -8.56% | $98.34M | 1% | |
DBO | -8.45% | $194.96M | 0.77% | |
KMLM | -8.03% | $323.94M | 0.9% | |
OILK | -7.65% | $78.02M | 0.69% | |
WEAT | -7.12% | $125.22M | 0.28% | |
USO | -7.08% | $1.07B | 0.6% | |
DBA | -5.66% | $860.62M | 0.93% | |
COMT | -4.09% | $733.59M | 0.48% | |
SGOV | -3.91% | $32.87B | 0.09% | |
BIL | -2.78% | $36.90B | 0.1356% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
XBIL | -0.09% | $644.91M | 0.15% | |
DBC | -0.35% | $1.36B | 0.87% | |
AGZD | 0.37% | $137.08M | 0.23% | |
UNG | -0.41% | $694.66M | 1.06% | |
GBIL | -0.74% | $5.79B | 0.12% | |
PDBC | -1.02% | $4.40B | 0.59% | |
XHLF | 1.08% | $1.08B | 0.03% | |
CORN | 1.67% | $65.96M | 0.2% | |
CCOR | 1.96% | $71.67M | 1.18% | |
CLOI | 2.16% | $868.21M | 0.4% | |
USCI | -2.25% | $205.06M | 1.07% | |
EQLS | -2.60% | $7.74M | 1% | |
GSG | -2.66% | $1.06B | 0.75% | |
TBLL | -2.75% | $2.04B | 0.08% | |
BIL | -2.78% | $36.90B | 0.1356% | |
BSMR | 2.90% | $219.49M | 0.18% | |
FTGC | 3.38% | $2.44B | 1.02% | |
FXY | 3.48% | $393.82M | 0.4% | |
SGOV | -3.91% | $32.87B | 0.09% | |
SHYD | 3.95% | $319.74M | 0.35% |
SeekingAlpha
Major deals, including Johnson & Johnsonâs $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly $1T in industry financial capacity. Read more here.
SeekingAlpha
Equity investors seeking long-term growth have focused on popular technology stocks in recent years. Read more here.
SeekingAlpha
Investors aligned their positions with the expectation that the second Trump administration will be favorable for banks, traditional energy producers, domestic manufacturing, and bitcoin.
SeekingAlpha
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking innovations like mRNA cancer vaccines and CRISPR-based therapies.
SeekingAlpha
This piece is part of a series that dives deeper into the most prevalent themes of this yearâs iteration of our flagship research piece, Charting Disruption. Click to read.
SeekingAlpha
Trade and investment, tax, immigration, and fiscal policies, and his approach to the Fed may impact some investments.